Can 2017 top 2016?

In the life sciences, 2016 brought us many significant developments, and thank goodness, it’s mostly exciting and great to talk about those in length. I am talking here about technological advancements, the many new applications next-generation sequencing is seeing, genetics moving into the clinic, precision medicine finding its mark in oncology and beyond, immunotherapy establishing itself as the leading weapon to attack cancer, and more.

The significance of these developments is further manifested with clinical omics taking shape, hospitals adopting new applications, and testing and treatments that are based on next-generation sequencing, omics data, and more. The results speak a clear language: improved diagnostic tests, and more precise therapeutics.

Here a few highlights – not an all-inclusive summary – of what made 2016 so exciting.


Next-generation sequencing matures

In 2016, we’ve reached a stage where the limitations of next-generation sequencing is not at the level of sequence data generation anymore, rather the limitations are associated Continue reading

Let’s get social while you focus on your science and business

First off, I am so excited to now be a part of the enlightenbio team. Second, I’m thrilled to play a role in social media management for our customers. As you all know, social media is such an essential part of who we are as individuals and as companies. Twitter, Facebook, LinkedIn, and Google+ are just a few of the social sites that have become part of our everyday lives. They have changed how people connect and how organizations succeed. Now more than ever, it is important to meet your customers where they are – online!  Maintaining corporate social pages can help ensure that potential customers learn  Continue reading